Welcome to Coulter Partners Global (English)

28 April 2022

Top hires for VC & PE portfolio companies Q1-2022

Search Highlights

Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Surgical robotics Switzerland
President US Immuno-oncology China
Chief Scientific Officer Oncology US
Chief Medical Officer Regenerative medicine US
Chief Medical Officer Oncology and gastrointestinal diseases China
Chief Commercial Officer DNA-based diagnostics Sweden
Chief Operating Officer Oncology US
Chief Financial Officer AI-enabled femtech Ireland
Head of Chemistry Precision therapeutics UK
Head of Sales Americas AI-enabled diagnostics Nordics
VP Clinical Development Precision biotherapeutics Singapore
VP General Manager Pharma Services Molecular diagnostics US
VP Marketing & Communications Rapid diagnostics Belgium
Chair RNA-based therapeutics Germany
Chair Drug discovery services UK
Partner Transatlantic life sciences investor UK

Newly opened projects include:

Function Focus area Location
CEO Immuno-oncology Belgium
Chief Development Officer Novel gene therapies Spain
Chief Medical Officer Age-related diseases US
Chief Medical Officer Digital therapeutics Sweden
Chief Scientific Officer Cell therapies US
Chief Commercial Officer Clinical research organisation US
VP Business Development & Strategy AI for drug discovery China
Head of Medicinal Chemistry Discovery tools UK
Head of CMC Bispecific antibodies & oncology Switzerland
Head of Biology Radiopharmaceuticals Germany
Commercial Head Europe Cloud-based neuro-diagnostics Nordics
Director Global Remote Care Medical devices France
Chair Oncology Finland/ US
Board Director Gene therapies Netherlands


A new version of Coulter Partners is available.